Investing.com - GW Pharma (NASDAQ:GWPH) ADR reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that topped expectations.
GW Pharma ADR announced earnings per share of $-0.08 on revenue of $148.22M. Analysts polled by Investing.com anticipated EPS of $-0.0525 on revenue of $145.09M.
GW Pharma ADR shares are up 85.6% from the beginning of the year, still down 1.49% from its 52 week high of $217.43 set on February 3. They are outperforming the Nasdaq which is up 9.5% from the start of the year.
GW Pharma ADR shares gained 0.13% in intra-day trade following the report.
GW Pharma ADR follows other major Healthcare sector earnings this month
GW Pharma ADR's report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Roche Holding ADR had missed expectations on February 1 with fourth quarter EPS of $1.21 on revenue of $15.88B, compared to forecast for EPS of $1.28 on revenue of $16.45B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar